Kevin Cameron

Director at AdvanCell

Capital raised by AdvanCell

$218.3M+$218.3M latest round

1 Form D filing · first filed Jun 2026 · Cambridge, MA

Career

1 company on file · founded 2026

AdvanCellBiotech · Cambridge, MAsince 2026

Director

Listed on AdvanCell's Form D filings

via EDGAR · Form D for AdvanCell1

DateCompanyFormAmountRole on filing

Jun 30, 2026AdvanCellForm D+$218.3M—

Form DJun 30, 2026 · AdvanCell+$218.3Mnot a signer

Last filing Jun 30, 2026

Kevin Cameron is on file as Director at AdvanCell in Cambridge, MA. AdvanCell has 1 Form D filing on record, $218.3M raised in total.

AdvanCell · 1

AdvanCell · 1

ADVC001Clinical-stage therapeutic

A 212Pb-based targeted alpha therapy for prostate cancer, advancing toward Phase III development on the back of the 2026 Series D financing.